Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Bausch Health Cos IncBHC-6.130.31-14.928.30-2,304.54%-0.40%57.80$8.02$2.29100,466$9.205

Detail of Bausch Health Cos Inc

 
CEO
Mr. Thomas J. Appio
Employees
20270
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Market cap
$3B

Company details

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$10.89B
Cost of goods (CoG)
-$3.18B
Gross profit (GP)
$7.70B
Operating expense (OE)
-$4.41B
Research and development (R&D)
-$723.87M
General and administrative (G&A)
-$3.68B
Operating income (OI)
$2.01B
Other income expense (OIE)
-$757.13M
Pretax income (PI)
-$382.06M
Tax (TAX)
-$170.72M
Net income (NI)
-$552.78M
Bausch Health Cos Inc
BHC • XNYS • US
$9.205
+1.86 (25.34%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$1.50
Margin profit
-5.12%
52 week low
$5.125
52 week high
$10.60
50-day simple moving average
$8.38
200-day simple moving average
$8.02
Percent held by insiders
11.28%
Percent held by institutions
78.89%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
BHC +21.53%
eps change
BHC -57.14%